Immunotech Biopharm Ltd (HKG:6978)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.5400
-0.0400 (-6.90%)
Jun 18, 2026, 11:57 AM HKT
Market Cap358.15M -80.7%
Revenue (ttm)n/a
Net Income-256.82M
EPS-0.47
Shares Out 617.50M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume227,000
Open0.5200
Previous Close0.5800
Day's Range0.5200 - 0.5700
52-Week Range0.5200 - 5.8300
Beta0.12
AnalystsStrong Buy
Price Target15.62 (+2,792.59%)
Earnings DateMar 20, 2026

About Immunotech Biopharm

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China. The company’s core product is EAL, a multi-target cellular immunotherapy product that has completed Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia that is in Phase II/III clinical trial; 6B... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 183
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6978
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements